Khaled Abou‐Aisha
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pharmaceutical Science top 10%
Papers in
-
- RNA Interference and Gene Delivery 3
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
- Photosynthetic Processes and Mechanisms 2
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Mohamed Z. Gad (12 shared papers)Mohamed El-Azizi (4 shared papers)Rania M. Hathout (2 shared papers)Tarek A. El‐Tayeb (1 shared paper)Laila Mahran (5 shared papers)R.A. Youness (5 shared papers)Hartmut Grammel (1 shared paper)Robin Ghosh (2 shared papers)
- Journals
- Annals of Oncology (3 papers)Colloids and Surfaces B Biointerfaces (2 papers)Drug Discoveries & Therapeutics (1 paper)Infection and Drug Resistance (1 paper)Neurochemical Research (1 paper)
- Partner nations
- EgyptGermanyUnited Kingdom
In The Last Decade
Khaled Abou‐Aisha
28 papers receiving 454 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 65
- Pharmaceutical Science 27
- Molecular Medicine 18
- Biomaterials 47
- Biochemistry 16
Countries citing papers authored by Khaled Abou‐Aisha
This map shows the geographic impact of Khaled Abou‐Aisha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Abou‐Aisha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Abou‐Aisha more than expected).
Fields of papers citing papers by Khaled Abou‐Aisha
This network shows the impact of papers produced by Khaled Abou‐Aisha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Abou‐Aisha. The network helps show where Khaled Abou‐Aisha may publish in the future.
Co-authors
The 25 scholars most cited alongside Khaled Abou‐Aisha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 76 | |
| 2 | 2020 | 51 | |
| 3 | 2012 | 48 | |
| 4 | 2014 | 42 | |
| 5 | 2016 | 39 | |
| 6 | 2022 | 25 | |
| 7 | 2019 | 23 | |
| 8 | 2012 | 22 | |
| 9 | 2013 | 19 | |
| 10 | 2011 | 14 | |
| 11 | 2010 | 13 | |
| 12 | 2020 | 10 | |
| 13 | 2015 | 10 | |
| 14 | 2016 | 9 | |
| 15 | 2017 | 8 | |
| 16 | 2011 | 8 | |
| 17 | 2013 | 8 | |
| 18 | 2022 | 6 | |
| 19 | 2017 | 5 | |
| 20 | 2024 | 4 |
About Khaled Abou‐Aisha
Khaled Abou‐Aisha is a scholar working on Molecular Biology, Cancer Research, Immunology, Physiology and Cardiology and Cardiovascular Medicine, having authored 29 papers that have together received 461 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Immune Cell Function and Interaction (5 papers), Nitric Oxide and Endothelin Effects (4 papers), RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Circular RNAs in diseases (2 papers) and Photosynthetic Processes and Mechanisms (2 papers). The work is most often cited by research in Cancer Research (65 citations), Pharmaceutical Science (27 citations), Molecular Medicine (18 citations), Biomaterials (47 citations) and Biochemistry (16 citations). Khaled Abou‐Aisha has collaborated with scholars based in Egypt, Germany and United Kingdom. Frequent co-authors include Mohamed Z. Gad, Mohamed El-Azizi, Rania M. Hathout, Tarek A. El‐Tayeb, Laila Mahran, R.A. Youness, Hartmut Grammel, Robin Ghosh, Sahar M. Abdel-Maksoud and Carsten Watzl. Their work appears in journals such as Annals of Oncology, Colloids and Surfaces B Biointerfaces, Drug Discoveries & Therapeutics, Infection and Drug Resistance and Neurochemical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.